Previous 10 |
MALVERN, Pa., April 5, 2019 /PRNewswire/ -- Realm Therapeutics plc (Nasdaq: RLM) (the "Company") today announced that the Company received written notice from the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based...
MALVERN, Pa., March 29, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM) today announces the completion of its previously announced Assets Disposal representing certain assets, which comprise the Vashe ® wound care royalty stream, an FDA 510(k...
MALVERN, Pa. , March 26, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high concentration HOCl, announced on March 15, 2019 that the listing of the Company's Ordinary Shares on AIM w...
Gainers: Vaxart (NASDAQ: VXRT ) +108% . Sorrento Therapeutics (NASDAQ: SRNE ) +34% . Conformis (NASDAQ: CFMS ) +23% . Blucora (NASDAQ: BCOR ) +20% . StoneCo (NASDAQ: STNE ) +19% . Realm Therapeutics ( RLM ) +19% . Iterum Therapeutics (NASDAQ: ITRM ) +18% . Altimmune (NASDAQ: A...
Thinly traded nano cap Realm Therapeutics ( RLM +9.6% ) is up, albeit on only 3,300 shares, following its announcement that shareholders have voted in favor of its proposed asset disposal to Urgo, U.S. The transaction should close on March 28. More news on: Realm Therapeutics PLC, Heal...
MALVERN, Pa. , March 15, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high concentration HOCl, announces that at the Company's general meeting, held today in connection with the ...
Gainers: BroadVision (NASDAQ: BVSN ) +36% . Frontier Communications (NYSE: FTR ) +26% . Tandem Diabetes Care (NASDAQ: TNDM ) +26% . Sea Limited (NYSE: SE ) +25% . Realm Therapeutics Plc ( RLM ) +16% . MeiraGTx Holdings plc (NASDAQ: MGTX ) +23% . Summit Therapeutics plc (NASDAQ:...
MALVERN, Pa. , Feb. 15, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high concentration HOCl, today provides an update on its previously announced strategic review. In li...
News, Short Squeeze, Breakout and More Instantly...
Realm Therapeutics plc Company Name:
RLM Stock Symbol:
NASDAQ Market:
MALVERN, Pa. , April 10, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM) today announces that its 2018 Annual Report is now available on the Company's website, www.realmtx.com , and will be posted to those shareholders who have not elected to receive the document electronically...
MALVERN, Pa., April 5, 2019 /PRNewswire/ -- Realm Therapeutics plc (Nasdaq: RLM) (the "Company") today announced that the Company received written notice from the Listing Qualifications Staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based...
MALVERN, Pa., March 29, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM) today announces the completion of its previously announced Assets Disposal representing certain assets, which comprise the Vashe ® wound care royalty stream, an FDA 510(k...